BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16360839)

  • 1. HLA antibody identification with single antigen beads compared to conventional methods.
    El-Awar N; Lee J; Terasaki PI
    Hum Immunol; 2005 Sep; 66(9):989-97. PubMed ID: 16360839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminex donor-specific crossmatches.
    Billen EV; Voorter CE; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2008 Jun; 71(6):507-13. PubMed ID: 18380779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
    Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New HLA class I epitopes defined by murine monoclonal antibodies.
    El-Awar N; Terasaki PI; Nguyen A; Lias M; Conger N
    Hum Immunol; 2010 May; 71(5):456-61. PubMed ID: 20156507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
    El-Awar NR; Akaza T; Terasaki PI; Nguyen A
    Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.
    Pei R; Lee JH; Shih NJ; Chen M; Terasaki PI
    Transplantation; 2003 Jan; 75(1):43-9. PubMed ID: 12544869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
    Fortin M; Hugo P
    Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine.
    Colombo MB; Haworth SE; Poli F; Nocco A; Puglisi G; Innocente A; Serafini M; Messa P; Scalamogna M
    Cytometry B Clin Cytom; 2007 Nov; 72(6):465-71. PubMed ID: 17397064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of HLA class I specific antibodies in patients with failed allografts.
    Mao Q; Terasaki PI; Cai J; El-Awar N; Rebellato L
    Transplantation; 2007 Jan; 83(1):54-61. PubMed ID: 17220791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens.
    Moses LA; Stroncek DF; Cipolone KM; Marincola FM
    Transfusion; 2000 Jul; 40(7):861-6. PubMed ID: 10924616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR antibody epitopes.
    Cai J; Kohanof S; Terasaki PI
    Clin Transpl; 2006; ():103-14. PubMed ID: 18365372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.